Clinical characteristics of participants overall and by sex
| Total | Women | Men | |
| N (%) | 2511 | 1414 (56) | 1097 (43) |
| Age (years) | 65.7±8.8 | 65.8±8.7 | 65.5±8.8 |
| Body mass index (kg/m2) | 28.1±5.3 | 27.6±5.8 | 28.7±4.5 |
| Systolic blood pressure (mm Hg) | 128±17.1 | 128±17.4 | 129±16.6 |
| Diastolic blood pressure (mm Hg) | 73.9±9.94 | 72.6±9.68 | 75.6±9.99 |
| Total cholesterol/HDL ratio | 3.47±1.05 | 3.27±0.95 | 3.74±1.11 |
| Diabetes (%) | 289 (12) | 121 (8.6) | 168 (15) |
| Smoker (%) | 217 (8.6) | 135 (9.5) | 82 (7.5) |
| eGFR (mL/min/1.73m2) | 81.2±18.2 | 79.7±18.5 | 83.1±17.5 |
| Antihypertensive treatment (%) | 1122 (45) | 583 (41) | 539 (49) |
| Lipid-lowering treatment (%) | 981 (39) | 498 (35) | 485 (44) |
| Glucose-lowering treatment (%) | 189 (7.5) | 89 (6.3) | 100 (9.1) |
| Left ventricular ejection fraction (%) | 68%±7% | 69%±6% | 66%±7% |
| E/e’ measurement | 6.99±2.20 | 7.37±2.31 | 6.49±1.95 |
eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein.